Oral AMXT 1501 Dicaprate in Combination With IV DFMO
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Cancer|Solid Tumor|Solid Carcinoma|Advanced Cancer|DIPG Brain Tumor|Ovary Cancer|Breast Cancer|Papillary Thyroid Cancer|Head and Neck Cancer|Gastric Cancer|Nsclc|Mesotheliomas Pleural|Mesothelioma Peritoneum|Esophageal Cancer|Diffuse Midline Glioma, H3 K27M-Mutant|Endometrial Cancer|Cervical Cancer|Melanoma|Colorectal Cancer|Glioma, Malignant
Interventions: DRUG: AMXT1501|DRUG: DFMO
Sponsor: Aminex Therapeutics, Inc.